New England Biolabs: Jim Ellard, Sal Russello
Jul 07, 2022
Jim Ellard, CEO Of New England Biolabs, will retire Aug. 15. He will be succeeded by Salvatore (Sal) Russello, currently NEB's director of OEM & customized solutions. Ellard, who joined NEB in 1984 as a summer intern and became the firm's CEO in 2005, will remain chairman of the board of directors. Russello joined NEB in 2007 as associate director of business development and assumed his current role in 2017. Prior to NEB, he was director of reagent marketing at Caliper Life Sciences, now part of PerkinElmer, and before that, business development manager at Cell Signaling Technology.